Envista Holdings Corporation reported its earnings for the full year ended December 31, 2025. Sales for the period increased by 8.3 percent, with total sales for the year reaching USD 2.69 billion. Core sales grew by 6.5 percent in the same period. The impact of foreign currency exchange rates contributed an additional 1.6 percent to sales growth. Envista’s management highlighted ongoing execution of its growth strategy, which includes evaluating potential acquisitions that align with or expand its current portfolio. The company continues to focus on delivering dental consumables, solutions, technologies, and services to support patient care and enhance dental practice capabilities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envista Holdings Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001757073-26-000011), on February 12, 2026, and is solely responsible for the information contained therein.